Bone Biologics Equity Warrants Exp 13th Oct 2026 BBLGW:NASDAQ

RT Quote | NASDAQ | USD
Last | 10/04/22 EDT
0.14UNCH (UNCH)
52 week range
0.09 - 1.80
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.14
  • 52 Week High1.80
  • 52 Week High Date11/02/21
  • 52 Week Low0.09
  • 52 Week Low Date09/23/22

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.14
  • 52 Week High1.80
  • 52 Week High Date11/02/21
  • 52 Week Low0.09
  • 52 Week Low Date09/23/22
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Bone Biologics Equity Warrants Exp 13th Oct 2026

 

Content From Our Affiliates

Profile

MORE
Bone Biologics Corporation is a medical device company focused on developing and marketing orthobiologic products. The Company is also focused on bone regeneration in spinal fusion using the recombinant human protein, known as NELL-1/DBX. The NELL-1/DBX medical device is a combination product which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The NELL-1/DBX Fusion Device offers a range of procedures including Spine...
Don Hankey
Chairman of the Board
Jeffrey Frelick
President, Chief Executive Officer, Chief Operating Officer
Deina Walsh CPA
Chief Financial Officer
Address
2 Burlington Woods Dr Ste 100
Burlington, MA
01803-4551
United States